248 related articles for article (PubMed ID: 22877654)
1. Ten common questions (and their answers) about off-label drug use.
Wittich CM; Burkle CM; Lanier WL
Mayo Clin Proc; 2012 Oct; 87(10):982-90. PubMed ID: 22877654
[TBL] [Abstract][Full Text] [Related]
2. Off-label drug use: the bevacizumab story.
Stewart MW
Mayo Clin Proc; 2013 Mar; 88(3):305. PubMed ID: 23489456
[No Abstract] [Full Text] [Related]
3. In reply.
Wittich CM; Burkle CM; Lanier WL
Mayo Clin Proc; 2013 Mar; 88(3):305-6. PubMed ID: 23489457
[No Abstract] [Full Text] [Related]
4. Physicians' Perspectives on FDA Approval Standards and Off-label Drug Marketing.
Kesselheim AS; Woloshin S; Lu Z; Tessema FA; Ross KM; Schwartz LM
JAMA Intern Med; 2019 May; 179(5):707-709. PubMed ID: 30667474
[TBL] [Abstract][Full Text] [Related]
5. Patterns and predictors of off-label prescription of psychiatric drugs.
Vijay A; Becker JE; Ross JS
PLoS One; 2018; 13(7):e0198363. PubMed ID: 30024873
[TBL] [Abstract][Full Text] [Related]
6. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
[TBL] [Abstract][Full Text] [Related]
7. Off-label prescribing to children in the United States outpatient setting.
Bazzano AT; Mangione-Smith R; Schonlau M; Suttorp MJ; Brook RH
Acad Pediatr; 2009; 9(2):81-8. PubMed ID: 19329098
[TBL] [Abstract][Full Text] [Related]
8. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
[TBL] [Abstract][Full Text] [Related]
9. Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J; Motulsky A; Abrahamowicz M; Eguale T; Buckeridge DL; Tamblyn R
BMJ; 2017 Feb; 356():j603. PubMed ID: 28228380
[No Abstract] [Full Text] [Related]
10. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
[TBL] [Abstract][Full Text] [Related]
11. Off-label drug prescriptions in French general practice: a cross-sectional study.
Drogou F; Netboute A; Giai J; Dode X; Darmon D; Kassai B; Letrilliart L
BMJ Open; 2019 Apr; 9(4):e026076. PubMed ID: 30967407
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
13. Paracetamol prescribing in primary care: too little and too much?
Kazouini A; Mohammed BS; Simpson CR; Helms PJ; McLay JS
Br J Clin Pharmacol; 2011 Sep; 72(3):500-4. PubMed ID: 21592184
[TBL] [Abstract][Full Text] [Related]
14. Reducing off-label prescribing in psychiatry.
Hickie IB
Med J Aust; 2014 Feb; 200(2):65-6. PubMed ID: 24484086
[No Abstract] [Full Text] [Related]
15. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
Kannan S; Bahl A; Khosla PP
Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
[TBL] [Abstract][Full Text] [Related]
16. Off-Label Prescribing for Children with Migraines in U.S. Ambulatory Care Settings.
Lai LL; Koh L; Ho JA; Ting A; Obi A
J Manag Care Spec Pharm; 2017 Mar; 23(3):382-387. PubMed ID: 28230456
[TBL] [Abstract][Full Text] [Related]
17. Off-label prescribing in the treatment of dermatologic disease.
Sugarman JH; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2002 Aug; 47(2):217-23. PubMed ID: 12140467
[TBL] [Abstract][Full Text] [Related]
18. The Law and Practice of Off-Label Prescribing and Physician Promotion.
Syed SA; Dixson BA; Constantino E; Regan J
J Am Acad Psychiatry Law; 2021 Mar; 49(1):53-59. PubMed ID: 33234538
[TBL] [Abstract][Full Text] [Related]
19. Off-label and unlicensed use of medicinal products in the neonatal setting in the Slovak Republic.
Schweigertova J; Durisova A; Dolnikova D; Ondriasova E; Balazova M; Slezakova V; Kuzelova M
Pediatr Int; 2016 Feb; 58(2):126-31. PubMed ID: 26256925
[TBL] [Abstract][Full Text] [Related]
20. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
